Search research articles
Contact Us
Filters
Showing results (101-110 of 109) with videos related to
Page
of 11
Sort By:
You have reached the last page of results.
This site can display upto 109 results.
Oncogene
|
March 9, 2010
Higher sensitivity of Adamts12-deficient mice to tumor growth and angiogenesis
M El Hour, A Moncada-Pazos, S Blacher, et al.
Journal of Medicinal Chemistry
|
July 31, 1998
Design, synthesis, and pharmacological evaluation of conformationally constrained analogues of N,N'-diaryl- and N-aryl-N-aralkylguanidines as potent inhibitors of neuronal Na+ channels
M C Maillard, M E Perlman, O Amitay, et al.
Bioorganic & Medicinal Chemistry Letters
|
November 23, 2018
Development and characterization of a CNS-penetrant benzhydryl hydroxamic acid class IIa histone deacetylase inhibitor
Christopher A Luckhurst, Omar Aziz, Vahri Beaumont, et al.
Bioorganic & Medicinal Chemistry
|
September 10, 2011
Exploiting differences in caspase-2 and -3 S₂ subsites for selectivity: structure-based design, solid-phase synthesis and in vitro activity of novel substrate-based caspase-2 inhibitors
Michel C Maillard, Frederick A Brookfield, Stephen M Courtney, et al.
Journal of Medicinal Chemistry
|
February 16, 2007
Design, synthesis, and crystal structure of hydroxyethyl secondary amine-based peptidomimetic inhibitors of human beta-secretase
Michel C Maillard, Roy K Hom, Timothy E Benson, et al.
Journal of Medicinal Chemistry
|
July 11, 2022
Identification of a Potent, Selective, and Brain-Penetrant Rho Kinase Inhibitor and its Activity in a Mouse Model of Huntington's Disease
Tammy Ladduwahetty, Matthew R Lee, Michel C Maillard, et al.
Archives of Gynecology and Obstetrics
|
October 4, 2016
N Erb, P Dürig, U Dietz, et al.
ACS Medicinal Chemistry Letters
|
March 19, 2021
Evaluation of 5-(Trifluoromethyl)-1,2,4-oxadiazole-Based Class IIa HDAC Inhibitors for Huntington's Disease
Andrew J Stott, Michel C Maillard, Vahri Beaumont, et al.
Archives of Gynecology and Obstetrics
|
October 4, 2016
E Wight, C Küng, P Moreau, et al.
Page
of 11
Search research articles
Search
Showing results (101-110 of 109) with videos related to
Sort By:
Page
of 11
You have reached the last page of results.
This site can display upto 109 results.
Oncogene
|
March 9, 2010
Higher sensitivity of Adamts12-deficient mice to tumor growth and angiogenesis
M El Hour, A Moncada-Pazos, S Blacher, et al.
Journal of Medicinal Chemistry
|
July 31, 1998
Design, synthesis, and pharmacological evaluation of conformationally constrained analogues of N,N'-diaryl- and N-aryl-N-aralkylguanidines as potent inhibitors of neuronal Na+ channels
M C Maillard, M E Perlman, O Amitay, et al.
Bioorganic & Medicinal Chemistry Letters
|
November 23, 2018
Development and characterization of a CNS-penetrant benzhydryl hydroxamic acid class IIa histone deacetylase inhibitor
Christopher A Luckhurst, Omar Aziz, Vahri Beaumont, et al.
Bioorganic & Medicinal Chemistry
|
September 10, 2011
Exploiting differences in caspase-2 and -3 S₂ subsites for selectivity: structure-based design, solid-phase synthesis and in vitro activity of novel substrate-based caspase-2 inhibitors
Michel C Maillard, Frederick A Brookfield, Stephen M Courtney, et al.
Journal of Medicinal Chemistry
|
February 16, 2007
Design, synthesis, and crystal structure of hydroxyethyl secondary amine-based peptidomimetic inhibitors of human beta-secretase
Michel C Maillard, Roy K Hom, Timothy E Benson, et al.
Journal of Medicinal Chemistry
|
July 11, 2022
Identification of a Potent, Selective, and Brain-Penetrant Rho Kinase Inhibitor and its Activity in a Mouse Model of Huntington's Disease
Tammy Ladduwahetty, Matthew R Lee, Michel C Maillard, et al.
Archives of Gynecology and Obstetrics
|
October 4, 2016
N Erb, P Dürig, U Dietz, et al.
ACS Medicinal Chemistry Letters
|
March 19, 2021
Evaluation of 5-(Trifluoromethyl)-1,2,4-oxadiazole-Based Class IIa HDAC Inhibitors for Huntington's Disease
Andrew J Stott, Michel C Maillard, Vahri Beaumont, et al.
Archives of Gynecology and Obstetrics
|
October 4, 2016
E Wight, C Küng, P Moreau, et al.
Page
of 11